Reprogram Biosciences, a preclinical oncology biotechnology company developing mRNA-based therapeutics to treat solid tumors, today announced the close of its seed financing. The close brings total ...

Two teams of researchers have developed a cell reprogramming technology that converts rogue disease-causing T cells from our immune system into protective T reg cells. These cells help ensure that the ...

A recent commentary article published in the New England Journal of Medicine highlights how targeted dietary manipulations could reprogram tumor biology. The possibility that diet could improve cancer ...